Aditi Kothari

1.1k total citations · 1 hit paper
10 papers, 523 citations indexed

About

Aditi Kothari is a scholar working on Epidemiology, Otorhinolaryngology and Oncology. According to data from OpenAlex, Aditi Kothari has authored 10 papers receiving a total of 523 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Epidemiology, 3 papers in Otorhinolaryngology and 3 papers in Oncology. Recurrent topics in Aditi Kothari's work include Head and Neck Cancer Studies (3 papers), PARP inhibition in cancer therapy (3 papers) and CAR-T cell therapy research (2 papers). Aditi Kothari is often cited by papers focused on Head and Neck Cancer Studies (3 papers), PARP inhibition in cancer therapy (3 papers) and CAR-T cell therapy research (2 papers). Aditi Kothari collaborates with scholars based in United States, India and Netherlands. Aditi Kothari's co-authors include Constantia Pantelidou, Gerburg M. Wulf, Geoffrey I. Shapiro, Jennifer L. Guerriero, Olmo Sonzogni, Jos Jonkers, Emily Cheney, Peter Bouwman, Jocelin Pinto and Jessica A. Castrillon and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cancer Research and International Journal of Molecular Sciences.

In The Last Decade

Aditi Kothari

8 papers receiving 521 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

PARP Inhibitor Efficacy Depends on CD8+ T-cell Recruitment via Intratumoral STING Pathway Activation in BRCA-Deficient Models of Triple-Negative Breast Cancer

2019 476 citations Constantia Pantelidou, Olmo Sonzogni et al. Cancer Discovery profile →

Peers

Countries citing papers authored by Aditi Kothari

Since Specialization

Citations

This map shows the geographic impact of Aditi Kothari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aditi Kothari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aditi Kothari more than expected).

Fields of papers citing papers by Aditi Kothari

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aditi Kothari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aditi Kothari. The network helps show where Aditi Kothari may publish in the future.

Co-authorship network of co-authors of Aditi Kothari

This figure shows the co-authorship network connecting the top 25 collaborators of Aditi Kothari. A scholar is included among the top collaborators of Aditi Kothari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aditi Kothari. Aditi Kothari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

#	Work	Indexed citations
1	423P NF-κB signaling pathway activity leads to identification of novel molecular biomarkers in HPV-associated head and neck cancer 2024 ·Annals of Oncology ·Aditi Kothari, Travis P. Schrank, Wendell G. Yarbrough, (unknown)	0
2	Fosfomycin Susceptibility Among Multidrug-Resistant Extended-Spectrum β-Lactamase and Metallo-β-Lactamase–Producing Uropathogens in a Tertiary Care Hospital 2024 ·Infectious Diseases in Clinical Practice ·Aditi Kothari, (unknown), (unknown)	0
3	Comprehensive Viral Genotyping Reveals Prognostic Viral Phylogenetic Groups in HPV16-Associated Squamous Cell Carcinoma of the Oropharynx 2022 ·Molecular Cancer Research ·Travis P. Schrank, (unknown), Wesley H. Stepp, (unknown), William H. Weir, Nicholas R. Lenze, (unknown), (unknown), Aditi Kothari, Trevor Hackman, Siddharth Sheth, Shetal Patel, Stuart R. Jefferys, Natalia Issaeva, Wendell G. Yarbrough	7
4	Statin-Induced Myositis with Concomitant Myocarditis 2022 ·Cureus ·(unknown), Aditi Kothari, (unknown), (unknown)	2
5	STING agonism enhances anti-tumor immune responses and therapeutic efficacy of PARP inhibition in BRCA-associated breast cancer 2022 ·npj Breast Cancer ·Constantia Pantelidou, (unknown), Aditi Kothari, (unknown), Gerburg M. Wulf, Jennifer L. Guerriero, Geoffrey I. Shapiro	18
6	Direct Comparison of HPV16 Viral Genomic Integration, Copy Loss, and Structural Variants in Oropharyngeal and Uterine Cervical Cancers Reveal Distinct Relationships to E2 Disruption and Somatic Alteration 2022 ·Cancers ·Travis P. Schrank, (unknown), (unknown), Aditi Kothari, Di Wu, Wendell G. Yarbrough, Natalia Issaeva	10
7	Coagulation Signaling through PAR1 as a Therapeutic Target in Pancreatic Ductal Adenocarcinoma 2021 ·International Journal of Molecular Sciences ·Aditi Kothari, Matthew J. Flick	7
8	Detection and distribution of genotypes of Hepatitis C in a tertiary care hospital 2020 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), Aditi Kothari, (unknown)	2
9	Abstract 4490: PARP inhibitor efficacy depends on CD8+ T-cell recruitment via the STING pathway in BRCA-deficient models of triple-negative breast cancer 2019 ·Cancer Research ·Constantia Pantelidou, Olmo Sonzogni, Mateus de Oliveira Taveira, Anita K. Mehta, Dan Wang, Aditi Kothari, (unknown), Tanvi H. Visal, Jennifer L. Guerriero, Gerburg M. Wulf, Geoffrey I. Shapiro	1
10	PARP Inhibitor Efficacy Depends on CD8+ T-cell Recruitment via Intratumoral STING Pathway Activation in BRCA-Deficient Models of Triple-Negative Breast Cancer breakdown → 2019 ·Cancer Discovery ·Constantia Pantelidou, Olmo Sonzogni, Mateus de Oliveira Taveira, Anita K. Mehta, Aditi Kothari, Dan Wang, Tanvi H. Visal, (unknown), Jocelin Pinto, Jessica A. Castrillon, Emily Cheney, Peter Bouwman, Jos Jonkers, Sven Rottenberg, Jennifer L. Guerriero, Gerburg M. Wulf, Geoffrey I. Shapiro	476

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact